SCHEMBL6604597

SCHEMBL6604597

O=C(O)C[C@@H]1COC(=O)N1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 2/20 0.53
ITGA5 P08648 2/20 0.53
ITGB3 P05106 1/20 0.53
ITGB2 P05107 1/20 0.53
ITGAV P06756 1/20 0.53
ITGA2B P08514 1/20 0.53
ITGB5 P18084 1/20 0.53
ITGAL P20701 1/20 0.53
GABRA1 P14867 2/20 0.42
GABRR1 P24046 2/20 0.42
SLC6A1 P30531 2/20 0.42
GABRA5 P31644 2/20 0.42
GABRB2 P47870 2/20 0.42
SLC6A12 P48065 2/20 0.42
SLC6A11 P48066 2/20 0.42
GABRA4 P48169 2/20 0.42
SLC6A13 Q9NSD5 1/20 0.36
IRAK4 Q9NWZ3 4/20 0.33
TSHR P16473 2/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3678052 1.00 ITGB1 (0.53) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL16045376 1.00 ITGB1 (0.53) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL17966413 0.85 ITGB1 (0.37) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL17966411 0.85 ITGB1 (0.37) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL19628798 0.82 IRAK4 (0.35) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL25255171 0.81 HTT (0.38) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL25254019 0.81 HTT (0.38) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL25291800 0.81 HTT (0.38) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL5671846 0.77 KMT2A (0.34) IRAK4GAACACNA1CSCN5AKCNH2
SCHEMBL2155526 0.77 KMT2A (0.34) IRAK4GAACACNA1CSCN5AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105229012-A Be used for the treatment of the Compounds and methods for of bacteriological infection ASTRAZENECA AB 2016-01-06 CN disclosed
CN-1222519-C Reverse hydroxamate inhibitors of matrix metalloproteinases ABBOTT LAB (US) 2005-10-12 CN disclosed
EP-1019400-B1 BENZO(5,6)CYCLOHEPTAPYRIDINE COMPOUNDS USEFUL AS FARNESYL PROTEIN TRANSFERASE INHIBITORS SCHERING CORP (US) 2004-08-11 EP disclosed
CN-1339032-A Reverse hydroxamate inhibitors of matrix metalloproteinases ABBOTT LAB (US) 2002-03-06 CN disclosed
EP-1019400-A1 BENZO(5,6)CYCLOHEPTAPYRIDINE COMPOUNDS USEFUL AS FARNESYL PROTEIN TRANSFERASE INHIBITORS SCHERING CORPORATION (US) 2000-07-19 EP disclosed
US-5939416-A INHIBIT RAS FUNCTION, USE FOR TREATING TUMOR CELLS EXPRESSING AN ACTIVATED RAS ONCOGENE IN MAMMALS SCHERING CORPORATION (US) 1999-08-17 US disclosed
WO-1998057970-A1 BENZO(5,6)CYCLOHEPTAPYRIDINE COMPOUNDS USEFUL AS FARNESYL PROTEIN TRANSFERASE INHIBITORS SCHERING CORPORATION (US) 1998-12-23 WO disclosed